NANOG and prostate carcinoma: In fact, both these studies showed that WT SPOP suppresses stem cell tracts promoting Nanog poly-ubiquitination; SPOP mutations determine a loss of this important activity, increasing Nanog levels and determining increased cancer stem cell traits of prostate cancers [138,139].